mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
1 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |